Gabapentin Therapy in Acute Phase Ophthalmic Herpes Zoster Patients: Post Herpetic Neuralgia

Authors

  • Iffat Taqiyah Medical Faculty Lampung University
  • Hendra Tarigan Sibero Medical Faculty Lampung University

Keywords:

Gabapentin, herpes zoster ophtalmicus, postherpetic neuralgia

Abstract

Herpes zoster (HZ) is one of skin disease caused by viral infection, characterized by rash and pain, developed within unilateral dermatome consequence by Varicella Zoster Virus (VZV) reactivation in infected nerve. One of complication of HZ is pain that persists after the rash dissappears called postherpetic neuralgia (PHN). Postherpetic neuralgia can be predicted by people aged more than 50 years, severe prodromal symptoms, and severe acute pain of HZ. No treatment of prevention therapy for PHN has been shown but early therapy for reducing pain is expected for better outcome. Theory of early therapy of PHN has been still questionable. A 73-years old- women presenting with multiple blisters on her right forehead and eyelid accompanied by pain since 4 days ago. Dermatological status region of orbitalis and frontalis dextra, ophtalmic division of trigeminal nerve level appears pustules with erythematous base, circumscript, multiple, regular, lenticular, confluence, zoosteriform. Diagnosis of this case is herpes zoster ophtalmicus dextra. Management of this case is Acyclovir 5x800 mg for 7 days, Gabapentin 2x300 mg for 7 days, and compress with NaCl 0,9%. Patient has better outcome and patient has PHN that persist 5 months after rash dissappears. In this case, Gabapentin therapy in the acute phase can not prevent PHN but has a good outcome for reducing pain.

References

Kang S, Amagai M, Bruckner AL, Enk AH, Morgolis DJ, McMichael AJ, et al. Flitzpatrick dermatology. Edisi ke-9. New York: McGrawHill. 2019. hlm 3035-64

Puja B, Deepak B, Sheeba A. Herpes –zoster: an update. Int J Med Res Health Sci. 2013;2(4):960-966. DOI:10.5958/j.2319-5886.2.4.154.

Wittek M. Advances in the diagnostics of Varizella Zoster Virus and Importance of Vaccination. J Lab Med. 2008;32(4). doi 10.1515/JLM.2008.041et.

Kartogwino S. 2011. 10 besar kelompok penyakit kulit. Palembang: Penerbitan Universitas Sriwijaya.

Maiya A dan Shenoy S. A clinical study of herpes zoster ophthalmicus. IOSR-JDMS. 2013; 12(6):9-13.

Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc. 2016 Sep 21;9:447-454. doi: 10.2147/JMDH.S106340. PMID: 27703368; PMCID: PMC5036669.

Gharibo C, Kim C. Neuropathic pain of postherpetic neuralgia. Pain Med News. 2011;9:84–92.

Tontodonati M, Ursini T, Polilli E, Vadini F, Di Masi F, Volpone D, Parruti G. Int J Gen Med. 2012; 5():861-71.

Babamahmoodi F, Alikhani A, Ahangarkani A, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of Iran from 2007 to 2013. Neurol Res Int. 2015. doi.org/10.1155/2015/896098.

Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc. 2016 Sep 21;9:447-454. doi: 10.2147/JMDH.S106340. PMID: 27703368; PMCID: PMC5036669.

Mounsey A, Matthew L, Slawson D, Am Fam Physician. 2005 Sep 15;72(6):1075-1080.

Oxman, M.N., et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. The New England Journal of Medicine. 2005. 352:2271-84. https://doi.org/10.1056/NEJMoa051016.

Ankit, S., Zeng, T.X., Chen, Y.X., Gupta, H.N., Shah, K. and Wang, X.W. The Current Treatment and Prevention of Post Herpetic Neuralgia. Yangtze Medicine, 2, 28-38. https://doi.org/10.4236/ym.2018.21003.

Baron R dan Wassner G. Prevention and treatment of postherpetic neuralgia. Lancet. 2006. 367(9506)186-8. https://doi.org/10.1016/S0140-6736(06)68010-0.

Van Wijck AJM, Opstelten W, Moons KGM, van Essen GA, Kalkman CJ, Verheij TJM. The PINE study: a randomised controlled trial of epidural steroids and local anaesthetics to prevent postherpetic neuralgia. Lancet 2006; 367: 219–24.

Catron T and Hern G. Case report: herpes zoster ophtalmicus. WestJEM. 2008;9:174-6.

Thomas SL, Wheeler JG, Hall AJ. Micronutrient intake and the risk of herpes zoster: a case–control study. Int J Epid. 2006;35:307–314. doi:10.1093/ije/dyi270.

Chen JY, Chang CY, Lin YS, Hu ML. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination. Population Health Management. 2012;15(6):391-7. DOI: 10.1089/pop.2012.1563.

Djuanda A. 2011. Ilmu Penyakit Kulit dan Kelamin. Edisi 6. Jakarta: Fakultas Kedokteran Universitas Indonesia.

Chandrakala C, Tharini GK. A clinical study on 100 cases of herpes zoster in a tertiary care hospital. Int J Sci Study. 2017;5(9):138-43.

Singh S, Madhwar S, Singh JP. Comparative study of gabapentin in combination with valacyclovir and valacyclovir alone in herpes zoster. IJSS. 2016;3(1):37-40.

Lee EG, Lee HJ, Hyun DJ, Min K, Kim DH, & Yoon MS. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. dermatologic therapy. 2016. 29(3):184-90. doi:10.1111/dth.12331.

Mycek MJ, Harvey RA, Champe PC, dan Fischer BD. 1997. Lippincott’s ilustrated reviews: pharmacology. Edisi ke-2. Philadelpia: Lippincott Raven Publisher.

Lapolla W, Digiorgio C, Haitz K, et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch Dermatol. 2011. 147:901–7.

Rullán M, Bulilete O, Leiva A, et al. Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. Trials 18, 24:2017. https://doi.org/10.1186/s13063-016-1729-y.

Bulilete O, Leiva A, Rullan M, Roca A, Llobera J. Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial. PLoS ONE 14(6): e0217335.

Eo GL, Hee JL, Dong JH, Kyunghoon M, Dong HK, Moon SY. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. Dermatol Ther. 2016;29(3).184-90.

Bulilete O, Leiva A, Rulla´n M, Roca A, Llobera J, on behalf of PHN Group. Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial. PLoS ONE. 2019. 14(6): e0217335. https://doi.org/10.1371/ journal.pone.0217335.

Berry JD dan Petersen KL. A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurol. 2005;65:444–7.

Published

2021-04-30

How to Cite

Iffat Taqiyah, & Hendra Tarigan Sibero. (2021). Gabapentin Therapy in Acute Phase Ophthalmic Herpes Zoster Patients: Post Herpetic Neuralgia. Medical Profession Journal of Lampung, 9(4), 720-726. Retrieved from http://journalofmedula.com/index.php/medula/article/view/240

Issue

Section

Artikel